Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence for mitochondrial dysfunction is provided by mutations in genes that are associated with mitochondria in familial PD [e.g., mitochondrial kinase PINK (PTEN-induced kinase 1) and Parkin (Valente et al., 2004;Poole et al., 2008)], and features of PD are caused by mitochondrial toxins (Bove ´et al., 2005).”
From Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies (2008) · cites this paper as Valente et al., 2004
In the citing paper
“Mutations in PARKIN and PINK1 are the leading causes of autosomal recessive PD [9, 10].”
From miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1) (2016) · cites this paper as [10]
In the citing paper
“Multiple neurodegenerative diseases have dysfunctional mitophagic processes in neurons, as described in Parkinson’s disease (PD) (16), Huntington’s disease (17), amyotrophic lateral sclerosis (ALS) (18), and Alzheimer’s disease (AD) (19,20).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [16]
In the citing paper
“A causal association has been established between autosomal recessive forms of PD and mutations affecting the mitophagy regulators PINK1 (PTEN‐induced putative kinase 1) and PRKN/PARK2 (Parkin RBR E3 ubiquitin protein ligase) (Kitada et al, 1998; Valente et al, 2004; Narendra et al, 2008; Matsuda et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Valente et al, 2004
In the citing paper
“The most studied mechanism for mitophagy in mammalian cells is mediated by the cytoplasmic E3 ubiquitin ligase PARKIN [210] and the mitochondrial membrane kinase PINK1 [211].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [211]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Self-citationChen, H.-K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M. C., Orr, H. T., Botas, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00349-0 · Cited by 414
Research works printed but not linked: 1
- A. H. Schapiraet al., Lancet2, 1269 (1989).
Cited by
Items 801–900 of 1,043
Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
Chai, C., & Lim, K. (2014) · Current Genomics · doi:10.2174/1389202914666131210195808 · Cited by 135
Hexokinases link DJ-1 to the PINK1/parkin pathway
Hauser, D. N., Mamais, A., Conti, M. M., Primiani, C. T., Kumaran, R., Dillman, A. A., Langston, R. G., Beilina, A., Garcia, J. H., Diaz-Ruiz, A., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0212-x · Cited by 107
Mitophagy and reactive oxygen species interplay in Parkinson’s disease
Xiao, B., Kuruvilla, J., & Tan, E. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00402-y · Cited by 124
Gadad, B. S., Britton, G. B., & Rao, K. S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110182 · Cited by 108
Genetic neuropathology of Parkinson's disease.
Cookson, M., Hardy, J., & Lewis, P. A. (2008) · PubMed Central · Cited by 108
Loh, S. H. Y., Francescut, L., Lingor, P., Bähr, M., & Nicotera, P. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402258 · Cited by 108
Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease
Ziegler, S. G., Eblan, M. J., Gutti, U., Hruska, K. S., Stubblefield, B. K., Göker-Alpan, Ö., LaMarca, M. E., & Sidransky, E. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.03.004 · Cited by 115
Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET
Ikawa, M., Okazawa, H., Kudo, T., Kuriyama, M., Fujibayashi, Y., & Yoneda, M. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.02.016 · Cited by 114
PINK1: The guard of mitochondria
Wang, N., Zhu, P., Huang, R., Wang, C., Sun, L., Lan, B., He, Y., Zhao, H., & Gao, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118247 · Cited by 107
Apoptosis and its Role in Parkinson’s Disease
Erekat, N. S. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch4 · Cited by 137
Agarwal, S., & Muqit, M. M. K. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.09.005 · Cited by 110
Self-citationTyrosine phosphorylation in mitochondria: A new frontier in mitochondrial signaling
Salvi, M., Brunati, A. M., & Toninello, A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.006 · Cited by 109
Emerging Roles of S -Nitrosylation in Protein Misfolding and Neurodegenerative Diseases
Nakamura, T., & Lipton, S. A. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1858 · Cited by 107
Bao, L., Avshalumov, M. V., & Rice, M. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2652-05.2005 · Cited by 107
Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 124
Kazlauskaite, A., & Muqit, M. M. K. (2015) · The FEBS Journal · doi:10.1111/febs.13127 · Cited by 106
Self-citationDi Carlo, M., Giacomazza, D., Picone, P., Nuzzo, D., & San Biagio, P. L. (2012) · Free Radical Research · doi:10.3109/10715762.2012.714466 · Cited by 106
Nagatsu, T., & Nagatsu, I. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1596-4 · Cited by 119
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The Gene PD Study
Tobin, J. E., Latourelle, J. C., Lew, M. F., Klein, C., Suchowersky, O., Shill, H. A., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304051.01650.23 · Cited by 106
The Dynamics of the Mitochondrial Organelle as a Potential Therapeutic Target
Stetler, R. A., Leak, R. K., Gao, Y., & Chen, J. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.158 · Cited by 106
Transgenic zebrafish models of neurodegenerative diseases
Sager, J. J., Bai, Q., & Burton, E. A. (2010) · Brain Structure and Function · doi:10.1007/s00429-009-0237-1 · Cited by 122
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
Camilleri, A., & Vassallo, N. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12264 · Cited by 105
Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation
Piccoli, C., Sardanelli, A. M., Scrima, R., Ripoli, M. C., Quarato, G., D’Aprile, A., Bellomo, F., Scacco, S., Michele, G. D., Filla, A., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9729-2 · Cited by 109
Cox, R. T., & Spradling, A. C. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.002378 · Cited by 107
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Hallett, P. J., Engelender, S., & Isacson, O. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1532-2 · Cited by 104
Mitophagy in Cardiovascular Diseases
Morciano, G., Patergnani, S., Bonora, M., Pedriali, G., Tarocco, A., Bouhamida, E., Marchi, S., Ancora, G., Anania, G., Wieckowski, M. R., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030892 · Cited by 113
PINK1 mutations in sporadic early‐onset Parkinson's disease
Tan, E., Yew, K., Chua, E., Puvan, K., Shen, H., Lee, E., Puong, K., Zhao, Y., Pavanni, R., Wong, M., et al. (2006) · Movement Disorders · doi:10.1002/mds.20810 · Cited by 105
A Mitochondrial Etiology of Neurodegenerative Diseases: Evidence from Parkinson's Disease
Khusnutdinova, E., Gilyazova, I., Ruiz‐Pesini, E., Derbeneva, O., Khusainova, R., Khidiyatova, I., Magzhanov, R., & Wallace, D. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.001 · Cited by 105
Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration
Arboleda, G., Morales, L. C., Benítez, B. A., & Arboleda, H. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.10.001 · Cited by 111
Ferrer, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.004 · Cited by 125
Drosophila as a Model to Study Mitochondrial Dysfunction in Parkinson's Disease
Guo, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009944 · Cited by 105
Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity
Zhang, Z., Miah, M. R., Culbreth, M. E., & Aschner, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1844-x · Cited by 107
Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models
Maulik, M., Mitra, S., Bult‐Ito, A., Taylor, B. E., & Vayndorf, E. M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00077 · Cited by 121
Ren, H., Zhai, W., Lu, X., & Wang, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.691881 · Cited by 114
Autosomal recessive parkinsonism
Bonifati, V. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70004-9 · Cited by 108
Liu, S., & Lu, B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001237 · Cited by 104
Nakamura, T., & Lipton, S. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3570 · Cited by 104
Unravelling mitochondrial pathways to Parkinson's disease
Celardo, I., Martins, L. M., & Gandhi, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12433 · Cited by 103
Drosophila Models of Parkinson's Disease
Whitworth, A. J. (2011) · Advances in genetics · doi:10.1016/b978-0-12-380860-8.00001-x · Cited by 123
Quality Control in Neurons: Mitophagy and Other Selective Autophagy Mechanisms
Evans, C. S., & Holzbaur, E. L. F. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.06.031 · Cited by 110
Mitra, S., Anjum, J., Muni, M., Das, R. C., Rauf, A., Islam, F., Emran, T. B., Semwal, P., Hemeg, H. A., Alhumaydhi, F. A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112877 · Cited by 107
The associations between Parkinson’s disease and cancer: the plot thickens
Feng, D. D., Cai, W., & Chen, X. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0043-z · Cited by 103
Woodroof, H. I., Pogson, J. H., Begley, M., Cantley, L. C., Deak, M., Campbell, D. G., van Aalten, D. M. F., Whitworth, A. J., Alessi, D. R., & Muqit, M. M. K. (2011) · Open Biology · doi:10.1098/rsob.110012 · Cited by 103
Self-citationRegulation of mitochondrial functions by protein phosphorylation and dephosphorylation
Lim, S., Smith, K. R., Lim, S., Tian, R., Lu, J., & Tan, M. (2016) · Cell & Bioscience · doi:10.1186/s13578-016-0089-3 · Cited by 111
Dagda, R. K., & Chu, C. T. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9255-1 · Cited by 102
PINK1 Triggers Autocatalytic Activation of Parkin to Specify Cell Fate Decisions
Zhang, C., Lee, S., Peng, Y., Bunker, E., Giaime, E., Shen, J., Zhou, Z., & Liu, X. (2014) · Current Biology · doi:10.1016/j.cub.2014.07.014 · Cited by 101
Structure of PINK1 and mechanisms of Parkinson's disease-associated mutations
Kumar, A., Tamjar, J., Waddell, A. D., Woodroof, H. I., Raimi, O. G., Shaw, A. M., Peggie, M., Muqit, M. M., & van Aalten, D. M. (2017) · eLife · doi:10.7554/elife.29985 · Cited by 102
Self-citationPost-translational Modifications of Key Machinery in the Control of Mitophagy
Wang, L., Qi, H., Tang, Y., & Shen, H.-M. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.08.002 · Cited by 101
Wang, Y., Gao, L., Chen, J., Li, Q., Huo, L., Wang, Y., Wang, H., & Du, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.757161 · Cited by 123
Iron homeostasis imbalance and ferroptosis in brain diseases
Long, H., Zhu, W., Wei, L., & Zhao, J. (2023) · MedComm · doi:10.1002/mco2.298 · Cited by 128
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 124
Expanding Insights on the Involvement of Endoplasmic Reticulum Stress in Parkinson's Disease
Wang, H., & Takahashi, R. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1524 · Cited by 102
Association of PGC-1alphapolymorphisms with age of onset and risk of Parkinson's disease
Clark, J., Reddy, S., Zheng, K., Betensky, R. A., & Simon, D. K. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-69 · Cited by 102
Mitochondrial dysfunction in Parkinson’s disease
Fukae, J., Mizuno, Y., & Hattori, N. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.12.002 · Cited by 104
Mitochondrial Quality Control and Dynamics in Parkinson's Disease
McCoy, M. K., & Cookson, M. R. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4019 · Cited by 101
Functional modulation of parkin through physical interaction with SUMO‐1
Um, J. W., & Chung, K. C. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21041 · Cited by 102
Tzoulis, C., Tran, G. T., Schwarzlmüller, T., Specht, K., Haugarvoll, K., Balafkan, N., Lilleng, P. K., Miletić, H., Biermann, M., & Bindoff, L. A. (2013) · Brain · doi:10.1093/brain/awt103 · Cited by 108
Autophagy: Detection, regulation and its role in cancer and therapy response
Hönscheid, P., Datta, K., & Muders, M. H. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.907932 · Cited by 104
Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases
Novellino, F., Saccà, V., Donato, A., Zaffino, P., Spadea, M. F., Vismara, M., Arcidiacono, B., Malara, N., Presta, I., & Donato, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031115 · Cited by 101
Autophagy in Parkinson’s Disease
Nechushtai, L., Frenkel, D., & Pinkas‐Kramarski, R. (2023) · Biomolecules · doi:10.3390/biom13101435 · Cited by 115
Brain CHIP: removing the culprits in neurodegenerative disease
Dickey, C. A., Patterson, C., Dickson, D. W., & Petrucelli, L. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.003 · Cited by 115
Jenner, P., Morris, H. R., Robbins, T. W., Goedert, M., Hardy, J., Ben-Shlomo, Y., Bolam, P., Burn, D., Hindle, J. V., Brooks, D., et al. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130175 · Cited by 100
Neural stem cells in Parkinson’s disease: a role for neurogenesis defects in onset and progression
Grand, J. N. L., González-Cano, L., Pavlou, M. A. S., & Schwamborn, J. C. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1774-1 · Cited by 112
Astaxanthin protects against MPP+-induced oxidative stress in PC12 cells via the HO-1/NOX2 axis
Ye, Q., Huang, B., Zhang, X., Zhu, Y., & Chen, X. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-156 · Cited by 103
Bornhorst, J., Chakraborty, S., Meyer, S., Lohren, H., Richter-Brockmann, S., Knight, A. L., Caldwell, K. A., Caldwell, G. A., Kärst, U., Schwerdtle, T., et al. (2013) · Metallomics · doi:10.1039/c3mt00325f · Cited by 108
Mitophagy in neurodegenerative diseases
Rodolfo, C., Campello, S., & Cecconi, F. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.004 · Cited by 100
The Dimensions of Primary Mitochondrial Disorders
Schlieben, L. D., & Prokisch, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.600079 · Cited by 112
Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases
Bartman, S., Coppotelli, G., & Ross, J. M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46030130 · Cited by 116
Muñoz, V. F. L., & Paricio, N. (2011) · Parkinson s Disease · doi:10.4061/2011/520640 · Cited by 112
Zhou, H., Falkenburger, B. H., Schulz, J. B., Tieu, K., Xu, Z., & Xia, X. G. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.242 · Cited by 99
Neuronal pathology in Parkinson?s disease
Schulz, J. B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1081-0 · Cited by 101
Cysteine-mediated redox signalling in the mitochondria
Bak, D. W., & Weerapana, E. (2014) · Molecular BioSystems · doi:10.1039/c4mb00571f · Cited by 99
The mitochondrial kinase PINK 1: functions beyond mitophagy
Voigt, A., Berlemann, L. A., & Winklhofer, K. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13655 · Cited by 108
Osgerby, L., Lai, Y.-C., Thornton, P. J., Amalfitano, J., Le Duff, C. S., Jabeen, I., Kadri, H., Miccoli, A., Tucker, J. H. R., Muqit, M. M. K., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01897 · Cited by 97
Self-citationElkouris, M., Kouroupi, G., Vourvoukelis, A., Papagiannakis, N., Kaltezioti, V., Matsas, R., Stefanis, L., Xilouri, M., & Politis, P. K. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00058 · Cited by 98
Gumeni, S., Papanagnou, E., Manola, M. S., & Trougakos, I. P. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03952-w · Cited by 108
Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases
Liu, B., Ruan, J., Chen, M., Li, Z., Manjengwa, G. M., Schlüter, D., Song, W., & Wang, X. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01233-8 · Cited by 109
Genes and the Environment in Neurodegeneration
Coppedè, F., Mancuso, M., Siciliano, G., Migliore, L., & Murri, L. (2006) · Bioscience Reports · doi:10.1007/s10540-006-9028-6 · Cited by 99
Genome-wide association studies: the key to unlocking neurodegeneration?
Gandhi, S., & Wood, N. W. (2010) · Nature Neuroscience · doi:10.1038/nn.2584 · Cited by 113
Self-citationG2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort
Bras, J. M., Guerreiro, R. J., Ribeiro, M. H., Januario, C., Morgadinho, A., Oliveira, C. R., Cunha, L., Hardy, J., & Singleton, A. (2005) · Movement Disorders · doi:10.1002/mds.20682 · Cited by 99
Genetic factors and manganese-induced neurotoxicity
Chen, P., Parmalee, N. L., & Aschner, M. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00265 · Cited by 106
Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
Abramov, A. Y., Gegg, M., Grunewald, A., Wood, N. W., Klein, C., & Schapira, A. H. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025622 · Cited by 98
Self-citationIncreased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers
Dzamko, N., Rowe, D. B., & Halliday, G. M. (2016) · Movement Disorders · doi:10.1002/mds.26529 · Cited by 98
Ren, X., Chen, L., Xie, J., Zhang, Z., Dong, G., Liang, J., Liu, L., Zhou, H., & Luo, P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4175353 · Cited by 103
Parkinson's: A Disease of Aberrant Vesicle Trafficking
Singh, P. K., & Muqit, M. M. K. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100818-125512 · Cited by 96
Self-citationKey genes and convergent pathogenic mechanisms in Parkinson disease
Coukos, R., & Krainc, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00812-2 · Cited by 127
Genetic determinants at the interface of cancer and neurodegenerative disease
Morris, L. G. T., Veeriah, S., & Chan, T. A. (2010) · Oncogene · doi:10.1038/onc.2010.127 · Cited by 98
Parkin Ubiquitinates and Promotes the Degradation of RanBP2
Um, J. W., Min, D. S., Rhim, H., Kim, J., Paik, S. R., & Chung, K. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504994200 · Cited by 109
Hatano, T., Kubo, S., Sato, S., & Hattori, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06403.x · Cited by 120
Grant, L. M., Kelm‐Nelson, C. A., Hilby, B., Blue, K. V., Rajamanickam, E. S. P., Pultorak, J. D., Fleming, S. M., & Ciucci, M. R. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23625 · Cited by 113
Apoptosis signal-regulating kinase 1 as a therapeutic target
Kawarazaki, Y., Ichijo, H., & Naguro, I. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.896903 · Cited by 103
p53 in neurodegenerative diseases and brain cancers
Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 104
Molecular signaling toward mitophagy and its physiological significance
Feng, D., Liu, L., Zhu, Y., & Chen, Q. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.034 · Cited by 102
Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1
Burbulla, L. F., Fitzgerald, J. C., Stegen, K., Westermeier, J., Thost, A.-K., Kato, H., Mokranjac, D., Sauerwald, J., Martins, L. M., Woitalla, D., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.103 · Cited by 97
PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control
Zhuang, N., Li, L., Chen, S., & Wang, T. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.396 · Cited by 95
Enhancing NAD+ salvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease
Lehmann, S., Loh, S. H. Y., & Martins, L. M. (2016) · Biology Open · doi:10.1242/bio.022186 · Cited by 96
Galvin, J. E. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0096-2 · Cited by 106
Neurodegenerative disorders: Parkinson's disease and Huntington's disease
Hague, S., Klaffke, S., & Bandmann, O. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.060186 · Cited by 127
Emerging therapies for Parkinson's disease: From bench to bedside
Tarazi, F. I., Sahli, Z. T., Wolny, M., & Mousa, S. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.05.010 · Cited by 129
Fitzgerald, J. C., Zimprich, A., Carvajal Berrio, D. A., Schindler, K. M., Maurer, B., Schulte, C., Bus, C., Hauser, A.-K., Kübler, M., Lewin, R., et al. (2017) · Brain · doi:10.1093/brain/awx202 · Cited by 96
Metadata
- Authors
- Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., Dallapiccola, B., Auburger, G., & Wood, N. W.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- CSS IRCCS, Mendel Institute, viale Regina Margherita 261, 00198 Rome, Italy.
- Goethe University Frankfurt (DE)
- Università Cattolica del Sacro Cuore (IT)
- National Institutes of Health (US)
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Valente, Enza Maria
- ORCID
- Venue
- Science
- Published
- 2004-05-21
- Volume
- 304
- Issue
- 5674
- Pages
- 1158-1160
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2136388422
- Cited by
- 3,481
- References
- 19
- Citations by year
- 2026: 101 · 2025: 140 · 2024: 168 · 2023: 133 · 2022: 158 · 2021: 187 · 2020: 182 · 2019: 158 · 2018: 167 · 2017: 189 · 2016: 147 · 2015: 151 · 2014: 158 · 2013: 177 · 2012: 163
- FWCI
- 109.31
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Parkinson's UK (G-4029)
- Brain Research Trust
- Deutsche Forschungsgemeinschaft
- Ministero della Salute
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, PINK1, mitochondrial dysfunction, dopaminergic neuron loss, consanguineous family, nonsense mutation, missense mutations, mitochondrial localization
- MeSH terms
- PTEN-Induced Putative Kinase, Amino Acid Sequence, Animals, Exons, Humans, Leupeptins, Membrane Potentials, Mitochondria, Molecular Sequence Data, Mutation, Neurons, Parkinson Disease, Protein Kinases, Transfection, Apoptosis, Protein Structure, Tertiary, Oxidative Stress, Codon, Nonsense, COS Cells, Mutation, Missense, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.